Agena Bioscience

🚀 Exciting News in PGx! 🚀 We are thrilled to announce the launch of an advanced solution in pharmacogenetic analysis—VeriDose® Core v2.0! 🎯 What’s new?  🔬 Updated gene targets aligned with AMP Tier 1 and Tier 2 recommendations  🧬 Obtain genotype and CNV calling simultaneously when run with VeriDose CYP2D6 CNV v2.0 Panel 💡 Enhanced software features for a smoother workflow Whether you’re looking to upgrade your existing panel or integrate a new solution, VeriDose Core v2.0 is designed to elevate your research. Ready to take your testing to the next level? Contact us today to learn more: https://bit.ly/3NQckkF #PGx #Pharmacogenetics #VeriDoseCore #MassARRAY 

Holiday vibes, happy tummies, and festive sweater glory! Our San Diego office turned up the festive cheer with a holiday-themed lunch, complete with ham, turkey, and all the fixings. But the fun didn’t stop there! We also had a holiday sweater contest—the competition was fierce and, in some cases, hilariously tacky. The cherry on top? A photo booth to capture all the smiles, laughs, and team spirit with work friends. Food, photos, and festive fashion—Happy Holidays from Agena Bioscience! #HolidayCheer #OfficeFun #FestiveSeason #FoodAndPhotos

🌟 What a fantastic gathering in Hamburg! 🌟 We’re thrilled to share the success of our recent Distributor and User Group Meeting for our EMEA partners. The event was filled with insightful discussions, knowledge sharing, and meaningful connections. A heartfelt thank you to everyone who participated – your enthusiasm and expertise are what make these meetings so impactful. We’re truly fortunate to collaborate with such incredible customers and distributors who are driving innovation and excellence in their fields. Stay tuned for more updates as we continue to build on the momentum from this amazing event. Together, we’re shaping the future! #EMEA #UserGroupMeeting #Partnerships #Collaboration #Innovation

Exciting news coming out of AMP 2024: Announcing a strategic partnership and presentation with Agena Bioscience to bridge critical gaps in detecting mutations not identified by next-generation sequencing (NGS) alone. https://hubs.ly/Q02YV4vF0 #AMP #next-generation sequencing

📸 Spotted at #AMP2024: Great workshops featuring leading experts in oncology and pharmacogenomics. 💡 Got questions about genomic analysis workflows? Our team at Booth 925 has answers! Stop by for a chat about: - Sample optimization  - Research efficiency  - High-throughput solutions  - Quality assurance  - And more!

🍿 Something's poppin' at #AMP2024! Visit Booth 925 for: - Fresh, hot popcorn  - Fresh perspectives on genomic analysis  - Fresh solutions for your research The perfect combo of treats and technology!  #AgenaBioscience #AMP2024 

Congratulations to Precision's Darren W. Davis, PhD on his presentation at AMP yesterday with Agena Bioscience presenting methods to bridge critical gaps in detecting mutations not identified by next-generation sequencing (NGS) alone. Got questions for Darren or our team? Stop by Booth 1311 or reach out to set up time to speak with Darren Davis, Glen Ferguson, Rob Fannon, Kristi Garner and Brian Hart. #AMP2024

📍 We're getting ready for #AMP2024! Stop by Booth 925 later this week to explore innovative solutions for genomic research and discover how we're advancing multi-gene analysis. See you there!  #GenomicResearch #AMP2024 

Who will be at AMP 2024? Swing by booth #925 to connect with our team and explore our latest solutions in oncology, pharmacogenomics, and more. Whether you're looking to streamline your workflows, improve testing analysis, or simply learn about the latest innovations, we've got something for you. Let’s chat and see how we can help your lab achieve its goals. ✨ See you at AMP 2024—we can’t wait to meet you! #AMP2024 #Oncology #Pharmacogenetics 

Looking for a more efficient mutation profiling platform for breast and lung cancer research? If so, you’ll want to check out these two posters at this year’s Association for Molecular Pathology (AMP) Annual Meeting & Expo:   Detection of common hotspot variants in PIK3CA and TP53 using Agena ClearSEEK™ on the MassARRAY® System (ST085). This study, in collaboration with the University of Tübingen, looks at how the Agena ClearSEEK PIK3CA and the Agena Custom ClearSEEK TP53 panels stack up against digital droplet PCR in profiling FFPE breast cancer samples. A comprehensive evaluation of a rapid, low DNA input and cost-effective, targeted lung panel using MassARRAY technology to identify clinically relevant somatic variants in lung cancer (ST001). This poster describes a somatic variant profiling comparison study of an Augusta University developed LDT using iPlex HS chemistry on the MassARRAY system to NGS in FFPE lung cancer samples. We hope to see you at AMP next week! Drop by our booth (#925) to say hello and learn more about MassARRAY technology. If you can’t make it to AMP, comment below to get more information about the posters and Agena’s oncology and PGx solutions.     #AMP2024 #MutationProfiling #Oncology